entity

OSK

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about OSK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
6Hypotheses
1Analyses
1Outgoing
0Incoming
3Experiments
4Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

OSK Reprogramming and Yamanaka Factors in Neurodegeneration

mechanism · 1351 words

Outgoing (1)

TargetRelationTypeStr
epigenetic clock resetcausesprocess0.90

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (6)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Reelin-Mediated Cytoskeletal Stabilization Protocol 0.689 neurodegeneration Selective vulnerability of entorhinal co
Partial OSK Reprogramming Reverses Epigenetic Aging Without 0.630 neurodegeneration Investigate mechanisms of epigenetic rep
Profilin-1 Cytoskeletal Checkpoint Enhancement 0.554 neurodegeneration Gene expression changes in aging mouse b
Epigenetic Reprogramming Required for Late-Stage Interventio 0.542 neurodegeneration What is the optimal therapeutic window f
AAV-PHP.eB-Medium OSK Expression Reverses Cortical Neuronal 0.520 neurodegeneration epigenetic reprogramming aging neurons
Cytoskeletal Transport Selectivity Enhancement 0.455 neurodegeneration How do host cell factors influence the c

Mentioning Analyses (1)

Scientific analyses that reference this entity

Investigate mechanisms of epigenetic reprogramming in aging neurons, including D

neurodegeneration | 2026-04-10 | 7 hypotheses Top: 0.700

Experiments (3)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
REL transcription factor mediates VLC ceramide-driven inflammation exploratory inflammation 0.750 0.00 innate immune cells proposed N/A
Levodopa Response Determinants in PSP — Biomarker-Guided Prediction St clinical Neurodegeneration 0.400 0.50 human proposed $5,460,000
Neural Stem Cell Therapy for Alzheimer's Disease clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Loss of endothelial CD2AP causes sex-dependent cerebrovascular dysfunction. [PMID:39892386] Vandal M, Institoris A, Reveret L, Korin Neuron 2025 1
Protective genetic variants against Alzheimer's disease. [PMID:40409316] Marino C, Malotaux V, Giudicessi A, Agui Lancet Neurol 2025 1
Proximity interactome of lymphatic VE-cadherin reveals mechanisms of junctional [PMID:39232006] Serafin DS, Harris NR, Bálint L, Douglas Nat Commun 2024 1
Reelin Functions, Mechanisms of Action and Signaling Pathways During Brain Devel [PMID:32604886] Jossin Y Biomolecules 2020 1
Neuronal migration. [PMID:11429281] Lambert de Rouvroit C, Goffinet AM Mech Dev 2001 1
Modulation of apolipoprotein E receptor-2 by ApoE4, amyloid β-peptide, reelin, a [PMID:41858499] ["Barger S", "Moerman-Herzog A"] Frontiers in molecular neurosc 2026 0
The Potential Molecular Mechanisms and Key Genes of Early Deterioration of Paren [PMID:41863408] ["Cen G", "Li J", "Wang J", "Chen Y", "L Current neurovascular research 2026 0
RELN biallelic variant as a candidate risk factor in a consanguineous Pakistani [PMID:41785923] ["Hashmi A", "Harripaul R", "Muhammad T" Journal of affective disorders 2026 0
Silibinin inhibits F-actin assembly leading to G2/M cell cycle arrest in human b [PMID:41349910] Fu J, Liu S, Zhao R, Liu W, Hayashi T et Biochem Pharmacol 2026 0
Small molecule intervention of actin-binding protein profilin1 reduces tumor ang [PMID:41386296] Gau D, Chawla P, Xu K, Welling N, Antone J Biol Chem 2026 0
F-Box and Leucine-Rich Repeat Protein 4 (FBXL4) Maintains Sarcomere Integrity an [PMID:41589689] Li X, He X, Hao X, Zhang Y, Zhao X et al Adv Sci (Weinh) 2026 0
APOE4-driven T cell dysregulation in Alzheimer's disease: single-cell genomics a [PMID:41673758] Zheng D, Gu J, Nao J, Sun M, Dong X J Neuroinflammation 2026 0
Proteomic analysis of plasma extracellular vesicles for predicting acute kidney [PMID:41720883] Li J, Xu L, Liu Y, Liu X, Li X et al. Sci Rep 2026 0
Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] Burdman Gabriel; Akkaoui Juliet; Colon N Neurology international 2026 0
Profillin-1 and Transgelin-2: Actin Binding Proteins Expression in Early and Adv [PMID:41911947] Shahid MA, Mushtaq S, Khan A, Naseeb U, Cancer Rep (Hoboken) 2026 0
Temporal and Spatial Gene Expression Dynamics in Neonatal HI Hippocampus with Fo [PMID:41677619] ["Smith M", "Natarajan E", "Lizama-Valen Cells 2026 0
Migration of dI5 Reelin-Lmx1b-Zfhx3 and Disabled-1-Lmx1b-Zfhx3 neurons contribut [PMID:41890024] ["Yvone G", "Chavez-Martinez C", "Mekonn bioRxiv : the preprint server 2026 0
Whisking Behaviour Reveals Stronger Evidence of Habituation in Homozygous Reeler [PMID:41844513] ["Simanaviciute U", "Cetin A", "Guy J", Genes, brain, and behavior 2026 0
Reln haploinsufficiency enhances fentanyl-induced locomotion and striatal activi [PMID:41890027] ["Litif C", "Libster A", "Desfor S", "Hu bioRxiv : the preprint server 2026 0
Immunoglobulin allotypes and [PMID:41848375] ["Pandey J", "Namboodiri A", "Nietert P" Journal of Alzheimer's disease 2026 0

Debates (4)

Multi-agent debates referencing this entity

Investigate mechanisms of epigenetic reprogramming in aging neurons, including D

closed · Rounds: 4 · Score: 0.50 · 2026-04-21

Investigate mechanisms of epigenetic reprogramming in aging neurons, including D

closed · Rounds: 0 · Score: 0.48 · 2026-04-21

Investigate mechanisms of epigenetic reprogramming in aging neurons, including D

closed · Rounds: 0 · Score: 0.51 · 2026-04-21

Investigate mechanisms of epigenetic reprogramming in aging neurons, including D

closed · Rounds: 4 · Score: 0.73 · 2026-04-21

Related Research

Hypotheses and analyses mentioning OSK in their description or question text

Cytoskeletal Transport Selectivity Enhancement

Score: 0.455 · neurodegeneration · 2026-04-27

Engineering motor protein adaptors to selectively misroute pathological seeds to degradative compartments